[Inaudible] Andrew, Nathan, and Mark. [Inaudible] There is 351,000 doses just in one per tower. It's fascinating. I don't know if you all got that 351,000 doses in one tower. We have the -- we have the -- we have the needles, so come on up. Come on up. And so, we got my men and they'll go preparing the pallets for the freezer. And we're looking for the freezer here. They move fast. Yeah. [Inaudible] Their pallet has five [Inaudible] five cabinets than -- then will hold -- this whole pallet holds 60 bundles. We're going to start the demonstration now. Let's get off. [Inaudible wow. [Inaudible] Hope these guys don't happen to [Inaudible] their homes very often. [Inaudible] It seems you try to help -- you want to help them. Right. [Inaudible] with the President. Yesterday. That's what the President says. I didn't -- but how long does it take to -- Two to three minutes About three minutes. Yeah. Yeah. And the amazing thing about this is that we have 350 freezers in this warehouse. And this section right here is 351,000 doses that we will -- everything in the freezer in this warehouse, that's over almost 130 million doses. We just signed up to purchase $600 million from Pfizer, as well as some amazing -- So, Ed is just going to give you a demo of -- of [Inaudible] All right. Good. 4:14 [Inaudible] Welcome, Mr. President. Thank you for visiting us today. Today, I'm going to talk through a couple of other ways that we make sure the vaccine is in proper temperature. [Inaudible] for research. First thing you want to know [Inaudible] those vaccines from freezer to active line. Once it is approved for shift, then you can see the bottom end of temperature from all the way to zero before going to the transfer mark. It's designed to maintain the negative 60 or below temperature range. I'll open it up for you so you can see what's inside. You can see we hold the dry ice around the bottom and the outsides to make sure it's safe from damage. Once the cart is moved to the line, we transfer the vaccine into our insulating conveyor [Inaudible] put it here by hand? They do. Yes, sir. Yup. It happens right up there, Mr. President. Oh. It happens there? Yup. Yup. And I was just explaining the box a little bit, each box is -- [Inaudible] [Inaudible] If you want. I insist. [Inaudible] Hello, Mr. President, distinguished guests. My name is Brian Cronk, process engineer for the vaccine shipping at Pfizer manufacturing. This is 6-months old. This was basically the warehouse space. In six months, we design, develop, install, and start up this entire line. These two lines are lines 101 and 102. These will produce 120 boxes an hour off of these two lines which is included to 700,000 doses per hour of product a day. So, it's really good. We got them running and planning ahead for those -- probably later this week. So, these have just been put in? Yes. So, haven't run these lines yet commercially? That's correct. Good, that's it. We'd run the other three lines over there -- Gotcha. Gotcha. These were just installed. Right Great help from your administration. The equipment must help. Yeah. That's -- that's why I wondered with this -- I was made aware of what was asked to do to help. So, I didn't know whether this was the particular spot here inside. Yes. That'll be done. Yup. Yup. It's been very fast concept. When will this be ready, this line begin to run? We will finish the commissioning of it next week. Good. Good. Can I ask you when you're ready to have [Inaudible] that you need and make the vaccine [Inaudible] We do. We have significant improvements in the capacity of the lipids. They were indeed one of the raw materials. But we're a bottleneck. But right now, thanks to the lots of things that we have done including helping from the Biden administration in rated orders through the production -- defense production. Now, we feel that we are going to run in -- in capacity. So, good news in vaccine manufacturing capacity. We will improve our weekly shipments, more than double from the next batch. Do you all plan to discuss the study showing that the one dose of the Pfizer vaccine is effective and therefore there is a consideration about delaying a second dose? Can you repeat the first one? The -- the study showing that you could delay the second dose of the Pfizer vaccine. No, there's no study. There's no study. There's no study. We haven't studied the -- ultimately, the delay. We -- we only have data up to 21 days when we had the news of the second. And -- We do not know what will happen if you do the -- administer the second, how long this duration of immunity will last. But are you looking at that -- that idea of doing only one dose and delaying the second one so you could then vaccinate more people? We don't think it will work with one right now. You don't think it will work? No, but we are looking at it. OK. Thank you. [Inaudible] They -- have been able to provide these ready-to-orders which means to allow suppliers to consider us a priority. I mean, at this facility. At this facility. At this facility. Thank you, sir You're welcome. Thank you.